The inhibition of Th17 immune response in vitro and in vivo by the carbosilane dendrimer 2G-NN16

Biomaterials

Volumn 33, Issue 15, 2012, Pages 4002-4009

  Gras, Rafael ^a,b   Relloso, Miguel ^a   García, María I ^a   Javier de la Mata, F ^b,c   Gómez, Rafael ^b,c   López Fernández, Luis A ^a   Muñoz Fernández, M Angeles ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Carbosilane dendrimer; IL17A; IL17F; Th17; Th17 mouse model

Indexed keywords

CARBOSILANE DENDRIMER; IL17A; IL17F; MOUSE MODELS; TH17;

DISEASE CONTROL; MAMMALS;

DENDRIMERS;

2G NN16; CARBOSILANE DENDRIMER; DENDRIMER; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; INTERLEUKIN 23; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SPLEEN CELL; TH17 CELL;

ANIMALS; CANDIDA ALBICANS; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; DENDRIMERS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; RECEPTORS, CCR6; SILANES; SPLEEN; TH17 CELLS; TIME FACTORS;

CANDIDA ALBICANS; MUS;

EID: 84858279008     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.02.018     Document Type: Article

References (55)

1. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007, 8:942-949.
2. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007, 204:1849-1861.
3. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8:950-957.
4. Miossec P., Korn T., Kuchroo V.K. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009, 361:888-898.
5. Nowak E.C., Noelle R.J. Interleukin-9 as a T helper type 17 cytokine. Immunology 2010, 131:169-173.
6. Hirota K., Martin B., Veldhoen M. Development, regulation and functional capacities of Th17 cells. Semin Immunopathol 2010, 32:3-16.
7. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
8. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
9. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003, 198:1951-1957.
10. Huang W., Na L., Fidel P.L., Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004, 190:624-631.
11. Zelante T., De Luca A., Bonifazi P., Montagnoli C., Bozza S., Moretti S., et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007, 37:2695-2706.
12. Conti H.R., Shen F., Nayyar N., Stocum E., Sun J.N., Lindemann M.J., et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009, 206:299-311.
13. Liang S.C., Long A.J., Bennett F., Whitters M.J., Karim R., Collins M., et al. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 2007, 179:7791-7799.
14. Matsuzaki G., Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007, 51:1139-1147.
15. Weber N., Ortega P., Clemente M.I., Shcharbin D., Bryszewska M., de la Mata F.J., et al. Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes. J Control Release 2008, 132:55-64.
16. Baker J.R. Dendrimer-based nanoparticles for cancer therapy. ASH Educ Program Book 2009, 2009:708-719.
17. Gunaseelan S., Gunaseelan K., Deshmukh M., Zhang X., Sinko P.J. Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs. Adv Drug Deliv Rev 2010, 62:518-531.
18. Dutta T., Jain N.K. Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer. Biochim Biophys Acta 2007, 1770:681-686.
19. Wang J., Sui M., Fan W. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr Drug Metab 2010, 11:129-141.
20. Gras R., Garcia M.I., Gomez R., de la Mata F.J., Munoz-Fernandez M.A., Lopez-Fernandez L.A. The carbosilane dendrimer 2G-NN16 represses Tc17 differentiation in primary T CD8+ lymphocytes. Mol Pharm 2011.
21. Gras R., Almonacid L., Ortega P., Serramia M.J., Gomez R., de la Mata F.J., et al. Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16. Pharm Res 2009, 26:577-586.
22. Bermejo J.F., Ortega P., Chonco L., Eritja R., Samaniego R., Mullner M., et al. Water-soluble carbosilane dendrimers: synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications. Chemistry 2007, 13:483-495.
23. Chonco L., Bermejo-Martin J.F., Ortega P., Shcharbin D., Pedziwiatr E., Klajnert B., et al. Water-soluble carbosilane dendrimers protect phosphorothioate oligonucleotides from binding to serum proteins. Org Biomol Chem 2007, 5:1886-1893.
24. Gonzalo T., Clemente M.I., Chonco L., Weber N.D., Diaz L., Serramia M.J., et al. Gene therapy in HIV-infected cells to decrease viral impact by using an alternative delivery method. Chem Med Chem 2010, 5:921-929.
25. Pion M., Serramia M.J., Diaz L., Bryszewska M., Gallart T., Garcia F., et al. Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer. Biomaterials 2010, 31:8749-8758.
26. Garcia-Merino I., de Las Cuevas N., Jimenez J.L., Gallego J., Gomez C., Prieto C., et al. The Spanish HIV BioBank: a model of cooperative HIV research. Retrovirology 2009, 6:27.
27. Gillum A.M., Tsay E.Y., Kirsch D.R. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 1984, 198:179-182.
28. Karpuzoglu E., Fenaux J.B., Phillips R.A., Lengi A.J., Elvinger F., Ansar Ahmed S. Estrogen up-regulates inducible nitric oxide synthase, nitric oxide, and cyclooxygenase-2 in splenocytes activated with T cell stimulants: role of interferon-gamma. Endocrinology 2006, 147:662-671.
29. Diez-Orejas R., Molero G., Rios-Serrano I., Vazquez A., Gil C., Nombela C., et al. Low virulence of a morphological Candida albicans mutant. FEMS Microbiol Lett 1999, 176:311-319.
30. Hurtrel B., Lagrange P.H., Michel J.C. Systemic candidiasis in mice. I.-Correlation between kidney infection and mortality rate. Ann Immunol (Paris) 1980, 131C:93-104.
31. Baghian A., Lee K.W. Elimination of Candida albicans from kidneys of mice during short-term systemic infections. Kidney Int 1991, 40:400-405.
32. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007, 148:32-46.
33. Kreymborg K., Etzensperger R., Dumoutier L., Haak S., Rebollo A., Buch T., et al. IL-22 is expressed by Th17 cells in an IL-23-Dependent Fashion, but not required for the Development of autoimmune encephalomyelitis. J Immunol 2007, 179:8098-8104.
34. Ivanov, McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
35. Chaudhry A., Rudra D., Treuting P., Samstein R.M., Liang Y., Kas A., et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent Manner. Science 2009, 326:986-991.
36. Fischer A. Human immunodeficiency: Connecting STAT3, Th17 and human mucosal immunity. Immunol Cell Biol 2008, 86:549-551.
37. Zhou L., Ivanov, Spolski R., Min R., Shenderov K., Egawa T., et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007, 8:967-974.
38. Oukka M. Th17 cells in immunity and autoimmunity. Ann Rheum Dis 2008, 67(Suppl. 3):iii26-iii29.
39. Hamada S., Umemura M., Shiono T., Tanaka K., Yahagi A., Begum M.D., et al. IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J Immunol 2008, 181:3456-3463.
40. Shibata K., Yamada H., Hara H., Kishihara K., Yoshikai Y. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 2007, 178:4466-4472.
41. Genovese M.C., Van den Bosch F., Roberson S.A., Bojin S., Biagini I.M., Ryan P., et al. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 2010, 62:929-939.
42. Hueber W., Patel D.D., Dryja T., Wright A.M., Koroleva I., Bruin G., et al. Effects of AIN457, a Fully human antibody to Interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Translational Med 2010, 2:52ra72.
43. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009, 58:1152-1167.
44. Seiderer J., Elben I., Diegelmann J., Glas J., Stallhofer J., Tillack C., et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008, 14:437-445.
45. Babaloo Z., Babaie F., Farhoodi M., Aliparasti M.R., Baradaran B., Almasi S., et al. Interleukin-17A and interleukin-17F mRNA expression in peripheral blood mononuclear cells of patients with multiple sclerosis. Iran J Immunol 2010, 7:202-209.
46. Kap Y.S., Jagessar S.A., van Driel N., Blezer E., Bauer J., van Meurs M., et al. Effects of early IL-17A neutralization on disease induction in a primate model of experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 2011, 6:341-353.
47. Bovenschen H.J., van de Kerkhof P.C., van Erp P.E., Woestenenk R., Joosten I., Koenen H.J. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol 2011, 131:1853-1860.
48. Jia X., Hu M., Wang C., Zhang F., Han Q., Zhao R., et al. Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis. Mol Vis 2011, 17:1493-1507.
49. Tanasescu C., Balanescu E., Balanescu P., Olteanu R., Badea C., Grancea C., et al. IL-17 in cutaneous lupus erythematosus. Eur J Intern Med 2010, 21:202-207.
50. Zrioual S., Ecochard R., Tournadre A., Lenief V., Cazalis M.-A., Miossec P. Genome-Wide Comparison between IL-17A- and IL-17F-Induced effects in human rheumatoid arthritis synoviocytes. J Immunol 2009, 182:3112-3120.
51. Hot A., Miossec P. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann Rheum Dis 2011, 70:727-732.
52. Gosselin A., Monteiro P., Chomont N., Diaz-Griffero F., Said E.A., Fonseca S., et al. Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection. J Immunol 2010, 184:1604-1616.
53. Li Q., Estes J.D., Schlievert P.M., Duan L., Brosnahan A.J., Southern P.J., et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009, 458:1034-1038.
54. Wang C., Kang S.G., Lee J., Sun Z., Kim C.H. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol 2009, 2:173-183.
55. Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009, 10:514-523.